Is PDS Biotechnology Corp (PDSB) overvalued? · $50.7M cap
PDS Biotechnology Corp (PDSB) is a biotechnology company listed on NASDAQ.
This page asks whether PDS Biotechnology Corp (PDSB) looks expensive on cached numbers — not a short thesis.
No cached income statement for PDSB, so there is no earnings base to call rich or cheap.
PDSB currently screens at market cap $50.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PDSB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PDSB stock page for the full model, not this heading.
Not investment advice.